These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1561892)

  • 1. Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients.
    Panza G; Monzani E; Sacerdote P; Penati G; Panerai AE
    Acta Psychiatr Scand; 1992 Mar; 85(3):207-10. PubMed ID: 1561892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin, beta-endorphin and vasoactive intestinal peptide in peripheral blood mononuclear cells of drug-naive schizophrenic patients treated with haloperidol compared to healthy controls.
    Mauri MC; Rudelli R; Vanni S; Panza G; Sicaro A; Audisio D; Sacerdote P; Panerai AE
    Psychiatry Res; 1998 Mar; 78(1-2):45-50. PubMed ID: 9579701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and gut neuropeptides in peripheral blood mononuclear cells.
    Panerai AE; Sacerdote P
    J Physiol Paris; 1993; 87(5):283-9. PubMed ID: 8298605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response.
    Beinfeld MC; Garver DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):601-9. PubMed ID: 1956989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
    Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
    Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN; Korpi ER; Kirch DG
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-endorphin and cholecystokinin 8 concentrations in peripheral blood mononuclear cells of autistic children.
    Brambilla F; Guareschi-Cazzullo A; Tacchini C; Musetti C; Panerai AE; Sacerdote P
    Neuropsychobiology; 1997; 35(1):1-4. PubMed ID: 9018016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes of beta-endorphin and cholecystokinin in peripheral blood mononuclear cells.
    Panerai AE; Manfredi B; Locatelli L; Rubboli F; Sacerdote P
    Ann N Y Acad Sci; 1991; 621():174-8. PubMed ID: 1830463
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
    Magliozzi JR; Hollister LE; Arnold KV; Earle GM
    Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects.
    Cugini P; Lucia P; Di Palma L; Re M; Canova R; Gasbarrone L; Cianetti A
    Clin Auton Res; 1992 Apr; 2(2):113-8. PubMed ID: 1386266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between plasma haloperidol concentrations and clinical results.
    Palao DJ; Araúxo A; Haro JM; Brunet M; Bernardo M
    Arch Gen Psychiatry; 1996 Dec; 53(12):1167-9. PubMed ID: 8956684
    [No Abstract]   [Full Text] [Related]  

  • 12. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects.
    Wodarz N; Fritze J; Riederer P; Beckmann H
    Biol Psychiatry; 1993 May; 33(10):727-33. PubMed ID: 8353168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients.
    Leone M; Sacerdote P; D'Amico D; Panerai AE; Bussone G
    Cephalalgia; 1993 Dec; 13(6):413-6. PubMed ID: 8313456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of neuropeptides in peripheral mononuclear cells.
    Sacerdote P; Rubboli F; Locatelli L; Ciciliato I; Mantegazza P; Panerai AE
    J Neuroimmunol; 1991 Apr; 32(1):35-41. PubMed ID: 1672130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
    Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of psychoactive drugs on lymphocyte neuropeptides.
    Sacerdote P; Ciciliato IA; Rubboli F; Panerai AE
    Ann N Y Acad Sci; 1990; 594():270-9. PubMed ID: 2143059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum haloperidol concentration and clinical response in schizophrenia.
    Kirch DG; Bigelow LB; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ
    Schizophr Bull; 1988; 14(2):283-9. PubMed ID: 3201181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuroleptic treatments on peripheral opioid secretion.
    Brambilla F; Facchinetti F; Petraglia F; Smeraldi E; Bellodi L; Brancato V; Genazzani AR
    Neuropsychobiology; 1987; 18(2):68-73. PubMed ID: 2897644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.